Sponsored by:

Nuclear Medicine: Page 234

Gamma Medica highlights JNM study
By AuntMinnie.com staff writers
Gamma Medica is touting study results showing that molecular breast imaging can detect invasive ductal carcinoma, ductal carcinoma in situ, and invasive lobular carcinoma, and can play a beneficial role in evaluating extent of disease and presence of multifocal disease for surgical treatment planning.
May 1, 2011
FLT may top FDG in early cancer detection
By AuntMinnie.com staff writers
A new clinical trial is investigating the use of the radioactive tracer molecule fluoro-L-thymidine with PET imaging (FLT-PET) to determine if it could improve the early detection of tumor growth during treatment for esophageal and lung cancer.
April 28, 2011
FDG-PET/CT defines head, neck tumors
By AuntMinnie.com staff writers
Combining CT with FDG-PET can significantly enhance the outline of tumors in head and neck cancer patients and influence treatment options compared to CT alone, according to research presented Friday at the Cancer Imaging and Radiation Therapy Symposium in Atlanta.
April 28, 2011
SNM's Clinical Trials Network: Progress despite growing pains
By Wayne Forrest
With 2.5 years under its belt, SNM's Clinical Trials Network is making progress on a number of fronts -- including two major clinical trials coming soon and increasing membership around the world -- that it hopes will contribute to the future of nuclear medicine and molecular imaging.
April 28, 2011
2011 04 25 11 11 12 526 Christian Paul 175
AuntMinnie.com Molecular Imaging Insider
By Wayne Forrest
April 24, 2011
Gamma Medica touts low-dose MBI study
By AuntMinnie.com staff writers
Gamma Medica is highlighting a study presented today at SNM's Breast Cancer Imaging: State of the Art 2011 meeting that indicates that low-dose molecular breast imaging (MBI) can be a useful adjunct and potential alternative to screening mammography in women with dense breasts.
April 21, 2011
BSGI can foster low-dose breast imaging
By AuntMinnie.com staff writers
U.S. researchers found that it may be possible to reduce the radiation dose of breast-specific gamma imaging (BSGI) procedures by as much as 60% using a lower dose of the radiopharmaceutical, according to a study presented this week at the Breast Cancer Imaging: State of the Art 2011 conference in Bethesda, MD.
April 21, 2011
Covidien posts Q2 results
By AuntMinnie.com staff writers
Healthcare technology firm Covidien posted increased sales in its second quarter of fiscal 2011.
April 20, 2011
GE launches new PET/CT system
By AuntMinnie.com staff writers
GE Healthcare has introduced its new Optima PET/CT 560 scanner, which features full 2-m head-to-toe body scanning, as well as dose reduction capabilities.
April 18, 2011
ASNC taps new CEO
By AuntMinnie.com staff writers
The American Society of Nuclear Cardiology (ASNC) has named Kathleen Flood as its CEO, effective June 1.
April 17, 2011
ImaginAb, UCLA establish licensing agreement
By AuntMinnie.com staff writers
Imaging agent developer ImaginAb and the University of California, Los Angeles (UCLA) have finalized a technology licensing agreement relating to fluorine chemistry.
April 17, 2011
OctreoPharm nets financing for PET tracer
By AuntMinnie.com staff writers
German nuclear medicine contrast firm OctreoPharm Sciences has completed financing for the clinical development of its SOMscan PET cancer diagnostic agent.
April 13, 2011
Previous Page
Page 234 of 440
Next Page